The journal retracts the February 2021 article cited above.
Following publication, the authors contacted the Editorial Office to request the retraction of the cited article, stating concerns regarding the use of an incorrect dataset in the published article. It was confirmed by the authors when they tried to repeat their experiments unsuccessfully. The findings and conclusions reported in the article are no longer supported by the data. An investigation was conducted in in accordance with Frontiers’ policies that confirmed this; therefore, the article is retracted.
This retraction was approved by the Chief Editors of Frontiers in Oncology and the Chief Executive Editor of Frontiers. The authors agree to this retraction.
Summary
Keywords
Emodin, AKT1, bioinformatics, DNA Repair, breast cancer
Citation
Frontiers Editorial Office (2023) Retraction: Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicin. Front. Oncol. 13:1337635. doi: 10.3389/fonc.2023.1337635
Received
13 November 2023
Accepted
13 November 2023
Published
07 December 2023
Approved by
Giuseppe Giaccone, Vice President Global Development, United States
Volume
13 - 2023
Updates
Copyright
© 2023 Frontiers Editorial Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.